David Bailey
Stock Analyst at Morgan Stanley
(3.53)
# 2,278
Out of 4,609 analysts
203
Total ratings
43.5%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Maintained: Hold | n/a | $29.88 | - | 30 | Aug 7, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $174.00 → $163.00 | $132.33 | +23.18% | 31 | Jul 21, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $22.40 → $23.90 | $15.90 | +50.31% | 15 | Jul 21, 2026 | |
| RMD ResMed | Maintained: Hold | $230 | $223.24 | +3.03% | 17 | Jul 13, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $2.90 → $3.50 | $2.20 | +59.09% | 2 | Jun 3, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Maintained: Sell | $32.90 | $44.37 | -25.84% | 35 | Jun 1, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Maintained: Buy | $40.00 | $41.84 | -4.40% | 10 | May 25, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $34.40 → $29.30 | $34.29 | -14.55% | 14 | May 6, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Downgraded: Sell | $25.20 → $20.30 | $22.22 | -8.64% | 18 | May 6, 2026 | |
| ASX: COH Cochlear Limited | Upgraded: Hold | $194.00 → $119.00 | $125.94 | -5.51% | 14 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $127.50 → $152.50 | $177.66 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.50 → $1.35 | $0.41 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.05 → $3.55 | $6.36 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.54 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.36 | $3.11 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $0.88 | n/a | 1 | Jan 21, 2021 |
ResMed Inc.
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $29.88
Upside: -
CSL Limited
Jul 21, 2026
Maintained: Buy
Price Target: $174.00 → $163.00
Current: $132.33
Upside: +23.18%
Telix Pharmaceuticals Limited
Jul 21, 2026
Maintained: Buy
Price Target: $22.40 → $23.90
Current: $15.90
Upside: +50.31%
ResMed
Jul 13, 2026
Maintained: Hold
Price Target: $230
Current: $223.24
Upside: +3.03%
Integral Diagnostics Limited
Jun 3, 2026
Maintained: Buy
Price Target: $2.90 → $3.50
Current: $2.20
Upside: +59.09%
Ramsay Health Care Limited
Jun 1, 2026
Maintained: Sell
Price Target: $32.90
Current: $44.37
Upside: -25.84%
Fisher & Paykel Healthcare Corporation Limited
May 25, 2026
Maintained: Buy
Price Target: $40.00
Current: $41.84
Upside: -4.40%
Ansell Limited
May 6, 2026
Maintained: Hold
Price Target: $34.40 → $29.30
Current: $34.29
Upside: -14.55%
Sonic Healthcare Limited
May 6, 2026
Downgraded: Sell
Price Target: $25.20 → $20.30
Current: $22.22
Upside: -8.64%
Cochlear Limited
Apr 23, 2026
Upgraded: Hold
Price Target: $194.00 → $119.00
Current: $125.94
Upside: -5.51%
Aug 15, 2024
Maintained: Buy
Price Target: $127.50 → $152.50
Current: $177.66
Upside: n/a
Feb 28, 2024
Maintained: Hold
Price Target: $1.50 → $1.35
Current: $0.41
Upside: n/a
Jan 31, 2024
Maintained: Buy
Price Target: $3.05 → $3.55
Current: $6.36
Upside: n/a
Aug 24, 2021
Maintained: Hold
Price Target: n/a
Current: $15.54
Upside: n/a
Jan 21, 2021
Maintained: Hold
Price Target: $0.36
Current: $3.11
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $0.88
Upside: n/a